Welcome to our dedicated page for Novanta news (Ticker: NOVT), a resource for investors and traders seeking the latest updates and insights on Novanta stock.
Novanta Inc. reports developments as a Nasdaq-listed supplier of core technology solutions for medical, life science and advanced industrial original equipment manufacturers. Its updates center on precision medicine, precision manufacturing, robotics and automation, and advanced surgery, including laser beam steering and scanning, laser sources, robotic and precision motion technologies, medical insufflators, endoscopic pumps and integrated operating room technologies.
Company news commonly covers quarterly earnings releases, conference calls, investor presentations, OEM design wins, product and technology collaborations, and capital actions tied to balance-sheet and securities structure. Recent themes include motion control and sensing technologies for robotics certification environments and tangible equity unit financing.
Novanta Inc. (Nasdaq:NOVT), a leader in technology solutions for medical and advanced industrial OEMs, announced that CEO Matthijs Glastra will present at the virtual J.P. Morgan Healthcare Conference on January 13, 2021. Novanta specializes in photonics, vision, and precision motion technologies, providing clients with high-performance sub-systems tailored to their requirements. The company's growth is driven by a team committed to innovation and customer success. For more information, visit www.novanta.com.
Novanta Inc. (Nasdaq: NOVT) announced that its CFO, Robert Buckley, will present at the CJS Securities 21st Annual New Ideas for the New Year Conference on January 13, 2021. Novanta specializes in technology solutions for medical and advanced industrial OEMs, leveraging expertise in photonics, vision, and precision motion. The company focuses on engineering high-performance components and subsystems tailored for demanding applications, contributing to its growth through innovation and customer success.
Novanta Inc. (NASDAQ: NOVT) reported third-quarter 2020 financial results, showing GAAP revenue of $142.9 million, down 7.2% from $154.1 million in Q3 2019. Operating income decreased to $11.9 million, and net income was $8.3 million, compared to $12.8 million and $8.9 million, respectively, in the prior year. Adjusted EBITDA was $30.2 million, slightly lower than $31.0 million in Q3 2019. The company generated significant operating cash flow of $42.1 million, up from $7.0 million last year. Novanta anticipates fourth-quarter revenue of $144-$149 million, with continued focus on product innovation.
Novanta Inc. (Nasdaq: NOVT) announces that CEO Matthijs Glastra and CFO Robert Buckley will present at the Baird Global Industrial Conference on November 11, 2020. The company is renowned for providing core technology solutions, enhancing the competitive edge of medical and industrial OEMs through expertise in photonics, vision, and precision motion. Novanta's common shares are listed on Nasdaq under the ticker symbol 'NOVT'. For more details, visit www.novanta.com.
Novanta Inc. (Nasdaq: NOVT) will release its third quarter 2020 results on November 10, 2020. A conference call to discuss these results is scheduled for the same day at 10:00 a.m. ET. Investors can join by dialing (888) 346-3959 or through a live webcast on the company’s Investor Relations page. A replay of the call will be available three hours post-conclusion until January 4, 2020.
Novanta specializes in technology solutions for healthcare and industrial OEMs.